04/18/2017 - 1:08pm

In fact, J&J stated is now including the estimated impact of the Actelion transaction in its financial guidance.

04/18/2017 - 9:51am

Tecentriq (atezolizumab) was granted accelerated approval for the treatment of people with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin chemotherapy.

04/14/2017 - 2:51pm

State senators voted 22-9 in favor of approving a measure intended to help ease the state’s growing opioid epidemic.

04/12/2017 - 9:47am

Tardive dyskinesia is a neurological disorder characterized by repetitive involuntary movements, usually of the jaw, lips and tongue, such as grimacing, sticking out the tongue and smacking the lips.

04/10/2017 - 12:42pm

Company hopes to raise up to $100 million and list on the New York Stock Exchange under the ticker symbol BHVN.

04/10/2017 - 11:45am

Multiple news outlets state company could receive $2 billion in proceeds for the company it acquired from Merck KGaA’s Merck Serono in 2010.

04/10/2017 - 10:07am

Specialty pharmaceutical company could be acquired by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA.

04/07/2017 - 11:15am

Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) treat the virus in children ages 12 to 17. 

04/06/2017 - 9:28am

The company is targeting front store, retail pharmacy and specialty operations, including rolling out beer and wine and committing to a major upgrade in its cosmetics assortment.